Kiniksa Pharmaceuticals (UK), Ltd is an active company incorporated on 6 December 2018 with the registered office located in London, Greater London. Kiniksa Pharmaceuticals (UK), Ltd was registered 7 years ago.
Registered office address changed from 105 Piccadilly 105 Piccadilly Second Floor London W1J 7NJ England to 105 Piccadilly, Second Floor London W1J 7NJ on 28 November 2025
Submitted on 28 Nov 2025
Director's details changed for Mr Mark Anthony Ragosa on 17 November 2025
Submitted on 28 Nov 2025
Confirmation statement made on 14 November 2025 with no updates
Submitted on 14 Nov 2025
Registered office address changed from Kiniksa Pharmaceuticals (Uk) Ltd, Third Floor, 23 Old Bond Street London W1S 4PZ United Kingdom to 105 Piccadilly 105 Piccadilly London W1J 7NJ on 4 November 2025
Submitted on 4 Nov 2025
Registered office address changed from 105 Piccadilly 105 Piccadilly London W1J 7NJ England to 105 Piccadilly 105 Piccadilly Second Floor London W1J 7NJ on 4 November 2025
Submitted on 4 Nov 2025
Notice of agreement to exemption from audit of accounts for period ending 31/12/24
Submitted on 27 Sep 2025
Audit exemption statement of guarantee by parent company for period ending 31/12/24
Submitted on 27 Sep 2025
Consolidated accounts of parent company for subsidiary company period ending 31/12/24
Submitted on 27 Sep 2025
Audit exemption subsidiary accounts made up to 31 December 2024
Submitted on 27 Sep 2025
Appointment of Mr Douglas Barry as a secretary on 17 September 2025